BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nielsen OH, Rogler G, Hahnloser D, Thomsen OØ. Diagnosis and management of fistulizing Crohn’s disease. Nat Clin Pract Gastroenterol Hepatol. 2009;6:92-106. [PMID: 19153563 DOI: 10.1038/ncpgasthep1340] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Juillerat P, Pittet V, Vader J, Burnand B, Gonvers J, de Saussure P, Mottet C, Seibold F, Rogler G, Sagmeister M, Felley C, Michetti P, Froehlich F. Infliximab for Crohnʼs disease in the Swiss IBD Cohort Study: clinical management and appropriateness. European Journal of Gastroenterology & Hepatology 2010;22:1352-7. [DOI: 10.1097/meg.0b013e32833eaa8a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Amiot A, Setakhr V, Seksik P, Allez M, Treton X, De Vos M, Laharie D, Colombel JF, Abitbol V, Reimund JM, Moreau J, Veyrac M, Flourié B, Cosnes J, Lemann M, Bouhnik Y. Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID. Am J Gastroenterol 2014;109:1443-9. [PMID: 25091063 DOI: 10.1038/ajg.2014.183] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
3 Luceri C, D’ambrosio M, Bigagli E, Cinci L, Russo E, Staderini F, Cricchio M, Giudici F, Scaringi S. Involvement of MIR-126 and MMP9 in the Pathogenesis of Intra-Abdominal Fistulizing Crohn’s Disease: A Brief Research Report. Front Surg 2022;9:822407. [DOI: 10.3389/fsurg.2022.822407] [Reference Citation Analysis]
4 Ji XQ, Wang LX, Lu DG. Pulmonary manifestations of inflammatory bowel disease. World J Gastroenterol 2014; 20(37): 13501-13511 [PMID: 25309080 DOI: 10.3748/wjg.v20.i37.13501] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
5 Fu YM, Chen M, Liao AJ. A Meta-Analysis of Adalimumab for Fistula in Crohn's Disease. Gastroenterol Res Pract 2017;2017:1745692. [PMID: 29204155 DOI: 10.1155/2017/1745692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Iesalnieks I, Kilger A, Glass H, Obermeier F, Agha A, Schlitt HJ. Perforating Crohn's ileitis: delay of surgery is associated with inferior postoperative outcome. Inflamm Bowel Dis 2010;16:2125-30. [PMID: 20848506 DOI: 10.1002/ibd.21303] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
7 Costa Pereira C, Durães C, Coelho R, Grácio D, Silva M, Peixoto A, Lago P, Pereira M, Catarino T, Pinho S, Teixeira JP, Macedo G, Annese V, Magro F. Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease. PLoS One 2017;12:e0169102. [PMID: 28052094 DOI: 10.1371/journal.pone.0169102] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
8 Zawadzki A, Johnson LB, Bohe M, Johansson C, Ekelund M, Nielsen OH. An open prospective study evaluating efficacy and safety of a new medical device for rectal application of activated carbon in the treatment of chronic, uncomplicated perianal fistulas. Int J Colorectal Dis 2017;32:509-12. [PMID: 27878619 DOI: 10.1007/s00384-016-2726-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Baars JE, Kuipers EJ, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PC, Oldenburg B, Pierik M, Wahab PJ, van Bodegraven AA, van der Woude CJ; Initiative for Crohn and Colitis. Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands. Scand J Gastroenterol 2011;46:319-25. [PMID: 21299339 DOI: 10.3109/00365521.2010.536251] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
10 Truong A, Zaghiyan K, Fleshner P. Anorectal Crohn's Disease. Surg Clin North Am. 2019;99:1151-1162. [PMID: 31676054 DOI: 10.1016/j.suc.2019.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Plavšić I, Stimac T, Hauser G. Crohn's disease in women. Int J Womens Health 2013;5:681-8. [PMID: 24204175 DOI: 10.2147/IJWH.S38083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
12 Pellino G, Selvaggi F. Surgical treatment of perianal fistulizing Crohn's disease: from lay-open to cell-based therapy--an overview. ScientificWorldJournal 2014;2014:146281. [PMID: 25431776 DOI: 10.1155/2014/146281] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
13 M’Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg. 2014;6:208-219. [PMID: 25429322 DOI: 10.4240/wjgs.v6.i11.20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Baran B, Karaca C. Practical medical management of Crohn's disease. ISRN Gastroenterol 2013;2013:208073. [PMID: 24307950 DOI: 10.1155/2013/208073] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
15 Bor R, Fábián A, Szepes Z. Role of ultrasound in colorectal diseases. World J Gastroenterol 2016; 22(43): 9477-9487 [PMID: 27920469 DOI: 10.3748/wjg.v22.i43.9477] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lee JB, Yoon SG, Park KJ, Lee KY, Kim DD, Yoon SN, Yu CS; Korean IBD Study Group. The Clinical Features and Predictive Risk Factors for Reoperation in Patients With Perianal Crohn Diseases; A Multi-Center Study of a Korean Inflammatory Bowel Disease Study Group. Ann Coloproctol 2015;31:176-81. [PMID: 26576395 DOI: 10.3393/ac.2015.31.5.176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
17 Allocca M, Bonifacio C, Fiorino G, Spinelli A, Furfaro F, Balzarini L, Bonovas S, Danese S. Efficacy of tumour necrosis factor antagonists in stricturing Crohn’s disease: A tertiary center real-life experience. Digestive and Liver Disease 2017;49:872-7. [DOI: 10.1016/j.dld.2017.03.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
18 Lightner AL, Pemberton JH, Dozois EJ, Larson DW, Cima RR, Mathis KL, Pardi DS, Andrew RE, Koltun WA, Sagar P, Hahnloser D. The surgical management of inflammatory bowel disease. Curr Probl Surg 2017;54:172-250. [PMID: 28576304 DOI: 10.1067/j.cpsurg.2017.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
19 Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn’s disease. World J Gastroenterol 2013; 19(41): 7213-7216 [PMID: 24222969 DOI: 10.3748/wjg.v19.i41.7213] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
20 Schreiber S, Lawrance IC, Thomsen OØ, Hanauer SB, Bloomfield R, Sandborn WJ. Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:185-193. [PMID: 21083671 DOI: 10.1111/j.1365-2036.2010.04509.x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 90] [Article Influence: 9.1] [Reference Citation Analysis]
21 Uyeda JW, LeBedis CA, Penn DR, Murakami AM, Ramalingam V, Anderson SW, Soto JA, Gupta A. Ileal pouch-anal anastomosis surgery: Anatomy, postoperative complications, and image-guided intervention. Semin Ultrasound CT MR. 2013;34:299-310. [PMID: 23895903 DOI: 10.1053/j.sult.2013.03.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Lightner AL. Classification of Crohn's Disease and Inflammatory Bowel Disease Surgery-Related Fistulae. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications. Elsevier; 2018. pp. 111-8. [DOI: 10.1016/b978-0-12-811388-2.00009-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Nielsen OH, Seidelin JB, Munck LK, Rogler G. Use of biological molecules in the treatment of inflammatory bowel disease. J Intern Med. 2011;270:15-28. [PMID: 21241384 DOI: 10.1111/j.1365-2796.2011.02344.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
24 Zhang W, Zhu W, Li Y, Zuo L, Wang H, Li N, Li J. The respective role of medical and surgical therapy for enterovesical fistula in Crohn's disease. J Clin Gastroenterol 2014;48:708-11. [PMID: 24457944 DOI: 10.1097/MCG.0000000000000040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
25 Tabry H, Farrands PA. Update on anal fistulae: surgical perspectives for the gastroenterologist. Can J Gastroenterol 2011;25:675-80. [PMID: 22175058 DOI: 10.1155/2011/931316] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
26 Mahmoud NN, Halwani Y, Montbrun SD, Shah PM, Hedrick TL, Rashid F, Schwartz DA, Dalal RL, Kamiński JP, Zaghiyan K, Fleshner PR, Weissler JM, Fischer JP. Current management of perianal Crohn’s disease. Current Problems in Surgery 2017;54:262-98. [DOI: 10.1067/j.cpsurg.2017.02.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
27 Schwartz DA, Wang A, Ozbay B, Skup M, Eichner SF, Lin J, Chao J. Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton Placement. Inflamm Bowel Dis 2017;23:1860-6. [PMID: 28858069 DOI: 10.1097/MIB.0000000000001243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
28 Lee MJ, Parker CE, Taylor SR, Guizzetti L, Feagan BG, Lobo AJ, Jairath V. Efficacy of Medical Therapies for Fistulizing Crohn's Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16:1879-1892. [PMID: 29374617 DOI: 10.1016/j.cgh.2018.01.030] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 16.5] [Reference Citation Analysis]
29 de Las Casas SG, Alvarez-Gallego M, Martínez JAG, Alcolea NG, Serrano CB, Jiménez AU, Arranz MDM, Martín JLM, Migueláñez IP. Management of perianal fistula in inflammatory bowel disease: identification of prognostic factors associated with surgery. Langenbecks Arch Surg 2021;406:1181-8. [PMID: 33515317 DOI: 10.1007/s00423-021-02100-4] [Reference Citation Analysis]
30 Ruffolo C, Citton M, Scarpa M, Angriman I, Massani M, Caratozzolo E, Bassi N. Perianal Crohn’s disease: Is there something new? World J Gastroenterol 2011; 17(15): 1939-1946 [PMID: 21528071 DOI: 10.3748/wjg.v17.i15.1939] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
31 Chaudhry NA, Riverso M, Grajo JR, Moser PP, Zou F, Homsi M, Punglia DR, Zimmermann EM. A Fixed Stricture on Routine Cross-sectional Imaging Predicts Disease-Related Complications and Adverse Outcomes in Patients with Crohnʼs Disease: . Inflammatory Bowel Diseases 2017;23:641-9. [DOI: 10.1097/mib.0000000000001054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
32 Jin WS, Park JH, Lim KI, Tchah H, Ryoo E. Significance of Perianal Lesion in Pediatric Crohn Disease. Pediatr Gastroenterol Hepatol Nutr 2018;21:184-8. [PMID: 29992118 DOI: 10.5223/pghn.2018.21.3.184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Klag T, Goetz M, Stange EF, Wehkamp J. Medical Therapy of Perianal Crohn’s Disease. Viszeralmedizin. 2015;31:265-272. [PMID: 26557835 DOI: 10.1159/000434664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
34 Leutenegger M, Bruckner R, Spalinger MR, Lang S, Rogler G, Scharl M. Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial Cells. Inflamm Intest Dis 2018;2:211-8. [PMID: 30221148 DOI: 10.1159/000490052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Mansour M, Weston LA. Perianal infections: a primer for nonsurgeons. Curr Gastroenterol Rep 2010;12:270-9. [PMID: 20589540 DOI: 10.1007/s11894-010-0115-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Casella G, Villanacci V, Di Bella C, Antonelli E, Baldini V, Bassotti G. Pulmonary diseases associated with inflammatory bowel diseases. J Crohns Colitis. 2010;4:384-389. [PMID: 21122533 DOI: 10.1016/j.crohns.2010.02.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
37 Park EJ, Song KH, Baik SH, Park JJ, Kang J, Lee KY, Goo JI, Kim NK. The efficacy of infliximab combined with surgical treatment of fistulizing perianal Crohn's disease: Comparative analysis according to fistula subtypes. Asian J Surg 2018;41:438-47. [PMID: 28851611 DOI: 10.1016/j.asjsur.2017.06.005] [Cited by in Crossref: 6] [Article Influence: 1.2] [Reference Citation Analysis]
38 M’koma AE. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina 2022;58:567. [DOI: 10.3390/medicina58050567] [Reference Citation Analysis]
39 Schwartz DA, Tagarro I, Carmen Díez M, Sandborn WJ. Prevalence of Fistulizing Crohn's Disease in the United States: Estimate From a Systematic Literature Review Attempt and Population-Based Database Analysis. Inflamm Bowel Dis 2019;25:1773-9. [PMID: 31216573 DOI: 10.1093/ibd/izz056] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 18.0] [Reference Citation Analysis]
40 Nishigami T, Kataoka TR, Ikeuchi H, Torii I, Sato A, Tomitaz N, Tsujimura T. Adenocarcinomas associated with perianal fistulae in Crohn’s disease have a rectal, not an anal, immunophenotype. Pathology 2011;43:36-9. [DOI: 10.1097/pat.0b013e328340e4d6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
41 Jeong SY, Moon JS, Park KJ, Kim YS. Successful treatment of postoperative fistula with infliximab in a patient with Crohn's disease. Intest Res 2014;12:74-7. [PMID: 25349568 DOI: 10.5217/ir.2014.12.1.74] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
42 Rieder F, Latella G, Magro F, Yuksel ES, Higgins PDR, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d’Hoore A, Pellino G, Dignass AU. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. ECCOJC 2016;10:873-85. [DOI: 10.1093/ecco-jcc/jjw055] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 17.0] [Reference Citation Analysis]
43 O'Brien KJ, Parisi X, Shelman NR, Merideth MA, Introne WJ, Heller T, Gahl WA, Malicdan MCV, Gochuico BR. Inflammatory bowel disease in Hermansky-Pudlak syndrome: a retrospective single-centre cohort study. J Intern Med 2021;290:129-40. [PMID: 33423334 DOI: 10.1111/joim.13224] [Reference Citation Analysis]
44 García-Olmo D, Van Assche G, Tagarro I, Diez MC, Richard MP, Khalid JM, van Dijk M, Bennett D, Hokkanen SRK, Panés J. Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis. Adv Ther 2019;36:3503-18. [PMID: 31656013 DOI: 10.1007/s12325-019-01117-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
45 van Munster SN, Stolk MF, Kuypers KC, Wiezer R, Bollen TL. Magnetic resonance enterography findings of a gastrocolic fistula in Crohn's disease. Quant Imaging Med Surg 2016;6:482-5. [PMID: 27709089 DOI: 10.21037/qims.2016.08.06] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 Brown SR, Fearnhead NS, Faiz OD, Abercrombie JF, Acheson AG, Arnott RG, Clark SK, Clifford S, Davies RJ, Davies MM, Douie WJP, Dunlop MG, Epstein JC, Evans MD, George BD, Guy RJ, Hargest R, Hawthorne AB, Hill J, Hughes GW, Limdi JK, Maxwell-Armstrong CA, O'Connell PR, Pinkney TD, Pipe J, Sagar PM, Singh B, Soop M, Terry H, Torkington J, Verjee A, Walsh CJ, Warusavitarne JH, Williams AB, Williams GL, Wilson RG; ACPGBI IBD Surgery Consensus Collaboration. The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease. Colorectal Dis. 2018;20 Suppl 8:3-117. [PMID: 30508274 DOI: 10.1111/codi.14448] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
47 Protyniak B, Shutt T, Farmer R. Squamous Cell Carcinoma Originating from a Crohn's Enterocutaneous Fistula. Case Rep Surg 2017;2017:1929182. [PMID: 28487805 DOI: 10.1155/2017/1929182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
48 Zalieckas JM. Treatment of perianal Crohn’s disease. Seminars in Pediatric Surgery 2017;26:391-7. [DOI: 10.1053/j.sempedsurg.2017.10.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
49 Frei P, Biedermann L, Nielsen OH, Rogler G. Use of thiopurines in inflammatory bowel disease. World J Gastroenterol 2013; 19(7): 1040-1048 [PMID: 23467510 DOI: 10.3748/wjg.v19.i7.1040] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
50 M’Koma AE. Diagnosis of inflammatory bowel disease: Potential role of molecular biometrics. World J Gastrointest Surg 2014; 6(11): 208-219 [PMID: 25429322 DOI: 10.4240/wjgs.v6.i11.208] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
51 Bruckner RS, Nissim-Eliraz E, Marsiano N, Nir E, Shemesh H, Leutenegger M, Gottier C, Lang S, Spalinger MR, Leibl S, Rogler G, Yagel S, Scharl M, Shpigel NY. Transplantation of Human Intestine Into the Mouse: A Novel Platform for Study of Inflammatory Enterocutaneous Fistulas. J Crohns Colitis 2019;13:798-806. [PMID: 30590414 DOI: 10.1093/ecco-jcc/jjy226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
52 Efsen E, Saermark T, Hansen A, Bruun E, Brynskov J. Ramiprilate inhibits functional matrix metalloproteinase activity in Crohn's disease fistulas. Basic Clin Pharmacol Toxicol 2011;109:208-16. [PMID: 21535409 DOI: 10.1111/j.1742-7843.2011.00713.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
53 Shimshoni E, Adir I, Afik R, Solomonov I, Shenoy A, Adler M, Puricelli L, Sabino F, Savickas S, Mouhadeb O, Gluck N, Fishman S, Werner L, Salame TM, Shouval DS, Varol C, Auf dem Keller U, Podestà A, Geiger T, Milani P, Alon U, Sagi I. Distinct extracellular-matrix remodeling events precede symptoms of inflammation. Matrix Biol 2021;96:47-68. [PMID: 33246101 DOI: 10.1016/j.matbio.2020.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
54 Latella G, Caprilli R, Travis S. In favour of early surgery in Crohn's disease: a hypothesis to be tested. J Crohns Colitis. 2011;5:1-4. [PMID: 21272796 DOI: 10.1016/j.crohns.2010.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
55 Shimshoni E, Yablecovitch D, Baram L, Dotan I, Sagi I. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation. Gut 2015;64:367-72. [PMID: 25416065 DOI: 10.1136/gutjnl-2014-308048] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 9.7] [Reference Citation Analysis]
56 Pittet V, Juillerat P, Michetti P, Vader JP, Burnand B, Rogler G, Beglinger C, Seibold F, Mottet C, Felley C, Gonvers JJ, Froehlich F; Swiss IBD Cohort Study Group. Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort. Aliment Pharmacol Ther 2010;32:1007-16. [PMID: 20937046 DOI: 10.1111/j.1365-2036.2010.04434.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
57 Zeitz J, Fournier N, Labenz C, Biedermann L, Frei P, Misselwitz B, Scharl S, Vavricka SR, Sulz MC, Fried M, Rogler G, Scharl M. Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort. Inflamm Intest Dis. 2017;1:172-181. [PMID: 29922674 DOI: 10.1159/000458144] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Levin DN, Marcon MA, Rintala RJ, Jacobson D, Langer JC. Inflammatory Bowel Disease Manifesting After Surgical Treatment for Hirschsprung Disease. Journal of Pediatric Gastroenterology & Nutrition 2012;55:272-7. [DOI: 10.1097/mpg.0b013e31824f617a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 O’neill I, Scully C. Biologics in oral medicine: oral Crohn’s disease and orofacial granulomatosis: Biologics: oral Crohn’s and OFG. Oral Diseases 2012;18:633-8. [DOI: 10.1111/j.1601-0825.2012.01918.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
60 Scharl M, Frei P, Frei SM, Biedermann L, Weber A, Rogler G. Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn's disease. Eur J Gastroenterol Hepatol. 2014;26:114-118. [PMID: 24284372 DOI: 10.1097/meg.0b013e32836371a2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
61 Rieder F, Karrasch T, Ben-horin S, Schirbel A, Ehehalt R, Wehkamp J, de Haar C, Velin D, Latella G, Scaldaferri F, Rogler G, Higgins P, Sans M. Results of the 2nd Scientific Workshop of the ECCO (III): Basic mechanisms of intestinal healing. Journal of Crohn's and Colitis 2012;6:373-85. [DOI: 10.1016/j.crohns.2011.11.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
62 Lee JL, Yoon YS, Yu CS. Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon's Point of View. Ann Coloproctol 2021;37:5-15. [PMID: 33730796 DOI: 10.3393/ac.2021.02.08] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Yau YY, Leong RWL, Pudipeddi A, Redmond D, Wasinger VC. Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease. Mol Cell Proteomics. 2017;16:1244-1257. [PMID: 28490445 DOI: 10.1074/mcp.m116.066506] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
64 Goffin L, Fagagnini S, Vicari A, Mamie C, Melhem H, Weder B, Lutz C, Lang S, Scharl M, Rogler G, Chvatchko Y, Hausmann M. Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis. Inflammatory Bowel Diseases 2016;22:2041-57. [DOI: 10.1097/mib.0000000000000863] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
65 Freire P, Portela F, Donato MM, Ferreira M, Andrade P, Sofia C. CARD15 mutations and perianal fistulating Crohn’s disease: correlation and predictive value of antibiotic response. Dig Dis Sci. 2011;56:853-859. [PMID: 20632099 DOI: 10.1007/s10620-010-1331-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
66 Scharl M, Rogler G. Pathophysiology of fistula formation in Crohn's disease. World J Gastrointest Pathophysiol 2014; 5(3): 205-212 [PMID: 25133023 DOI: 10.4291/wjgp.v5.i3.205] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
67 Myers JN, Schäffer MW, Korolkova OY, Williams AD, Gangula PR, MʼKoma AE. Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease. Inflamm Bowel Dis 2014;20:1530-47. [PMID: 25078150 DOI: 10.1097/MIB.0000000000000144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
68 Maconi G, Tonolini M, Monteleone M, Bezzio C, Furfaro F, Villa C, Campari A, Dell-Era A, Sampietro G, Ardizzone S. Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn’s disease. Inflamm Bowel Dis. 2013;19:2737-2743. [PMID: 24193154 DOI: 10.1097/01.mib.0000436274.95722.e5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
69 Choi YS, Kim DS, Lee JB, Kim JK, Jung HJ, Lee SD, Song KH, Lee DH, Kim MJ. Clinical Features of Tuberculous Versus Crohn's Anal Fistulas, in Korea. J Crohns Colitis 2015;9:1132-7. [PMID: 26374663 DOI: 10.1093/ecco-jcc/jjv164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
70 Park MS, Kim WJ, Huh JH, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH. Crohn's duodeno-colonic fistula preoperatively closed using a detachable endoloop and hemoclips: a case report. Korean J Gastroenterol 2013;61:97-102. [PMID: 23458988 DOI: 10.4166/kjg.2013.61.2.97] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 Hu DD, Tan B, Qian JM. Solitary perianal rectal mass as the only manifestation of Crohn's disease. J Dig Dis 2018;19:177-9. [PMID: 29028149 DOI: 10.1111/1751-2980.12550] [Reference Citation Analysis]